Home›Stock Screener›Pfizer›Financial Statements

Pfizer Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Pfizer (PFIZER) reported revenue ₹2,520 Cr, net profit ₹718 Cr and EPS ₹157.92, with a net profit margin of 28.5% and ROE of 17.1%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore PFIZER Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 28.49% 2026 data
EBITDA Margin 33.93% 2026 data
Operating Margin 34.00% 2026 data
Return on Assets 14.59% 2026 data
Return on Equity 17.08% 2026 data

Balance Sheet Ratios

Current Ratio 41.34 2026 data
Equity Ratio 85.39% 2026 data
Asset Turnover 0.51 2026 data

PFIZER Revenue, Net Profit & EBITDA — Year-on-Year Growth

PFIZER YoY (March 2025 vs March 2026) — revenue +2.7%, net profit -6.5%, EBITDA -6.4%, expenses +8.0%. For live price, earnings ratios and company overview, see PFIZER stock price BSE.

Revenue Growth
+2.7%
Year-over-Year
Net Profit Growth
-6.5%
Year-over-Year
EBITDA Growth
-6.4%
Year-over-Year
Expense Growth
+8.0%
Year-over-Year
Assets Growth
+0.2%
Year-over-Year
Equity Growth
-0.3%
Year-over-Year
Operating Cash Flow Growth
+156.8%
Year-over-Year
Investing Cash Flow Growth
-231.5%
Year-over-Year
Financing Cash Flow Growth
+12.8%
Year-over-Year

PFIZER Income Statement — Revenue, EBITDA & Net Profit

Pfizer revenue ₹2,520 Cr, EBITDA ₹855 Cr, net profit ₹718 Cr, EPS ₹157.92 (2026) — net profit margin 28.5%. Review PFIZER earnings valuation to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 2,520 2,454 2,374 2,526 2,674 2,320 2,336 2,249 2,083 2,067 2,103 1,921
Expenses 1,665 1,541 1,558 1,616 1,775 1,526 1,579 1,516 1,468 1,617 1,586 1,470
EBITDA 855 913 816 910 898 793 757 733 615 450 517 450
Operating Profit Margin % 34.00% 32.00% 29.00% 33.00% 32.00% 32.00% 27.00% 27.00% 25.00% 18.00% 21.00% 21.00%
Depreciation 58 61 62 106 115 109 103 71 66 63 124 131
Interest 9 8 15 13 11 15 11 1 0 1 1 1
Profit Before Tax 976 1,016 746 824 773 669 643 660 548 517 402 238
Tax 258 249 195 200 160 171 133 231 188 180 179 138
Net Profit 718 768 551 624 613 498 509 429 360 337 223 100
Earnings Per Share (₹) 157.92 136.46 119.22 136.38 133.89 108.77 111.28 93.78 78.70 73.61 66.66 15.26

PFIZER Balance Sheet — Assets, Liabilities & Shareholders' Equity

PFIZER total assets ₹4,922 Cr, total equity ₹4,203 Cr, total liabilities ₹ Cr (2026) — ROE 17.1%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 4,922 4,911 4,229 4,001 3,901 3,266 4,405 3,940 3,690 3,261 2,914 2,612
Current Assets 3,803 3,513 2,738 2,525 2,397 1,925 3,048 2,715 2,417 2,051 1,630 1,253
Fixed Assets 698 724 713 749 869 894 973 886 950 902 895 944
Capital Work in Progress 20 8 0 8 1 3 1 0 1 15 3 13
Investments 473 0 0 0 0 0 0 0 0 0 4 0
Other Assets 0 4,180 3,516 3,244 3,030 2,369 3,432 3,054 2,739 2,343 2,011 1,655
LIABILITIES
Total Liabilities
Current Liabilities 92 124 87 136 183 99 137 37 52 62 36 32
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 4,203 4,217 3,596 3,207 2,864 2,393 3,396 3,011 2,683 2,419 2,118 1,973
Share Capital 46 46 46 46 46 46 46 46 46 46 46 46
Reserves & Surplus 4,157 4,172 3,550 3,162 2,819 2,347 3,350 2,966 2,637 2,373 2,072 1,927

PFIZER Cash Flow Statement — Operating, Investing & Financing

Pfizer operating cash flow ₹660 Cr, investing ₹-71 Cr, financing ₹-205 Cr, net cash flow ₹383 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 660 257 356 667 427 323 98 332 329 346 114
Investing Activities -71 54 -36 -575 -469 1,530 35 -238 -250 -701 68
Financing Activities -205 -235 -346 -181 -1,571 -164 -110 -110 -83 -62 -1
Net Cash Flow 383 75 -26 -88 -1,613 1,690 23 -17 -4 -417 181